Canada's Tekmira Pharmaceuticals Is Allowed to Provide Treatment to Those Infected With Ebola Virus

The U.S. Food and Drug Administration has authorized Tekmira Pharmaceuticals Corp. to provide an experimental drug to people with confirmed or suspected Ebola virus infections, the Canadian company said Monday.

Tekmira said it already has provided its drug, known as TKM-Ebola, to several patients under emergency protocols, and repeated infusions have been "well tolerated." The company didn't say how many patients have been...